Cardiovascular Events in Patients With Fabry Disease Natural History Data From the Fabry Registry
Manesh R Patel, Franco Cecchi, Marta Cizmarik, Ilkka Kantola, Ales Linhart, Kathy Nicholls, Joerg Strotmann, Jose Tallaj, Chien Tran Thi, Michael L West, Dana Beitner-Johnson, Ademola Abiose
Journal of the American College of Cardiology | ELSEVIER SCIENCE INC | Published : 2011
The Fabry Registry is sponsored by Genzyme Corporation (Cambridge, Massachusetts). Drs. Patel, Strotmann, and Abiose served on the Genzyme-sponsored Fabry Registry Boards of Advisors. Drs. Cecchi and Linhart have received research support and speaking fees from Genzyme and from Shire HGT. Ms. Cizmarik and Dr. Beitner-Johnson are full-time employees of Genzyme. Dr. Kantola has received speaking fees and travel funds from Genzyme and from Shire HGT. Dr. Nicholls has received travel and research support from Genzyme, Shire HGT, and Amicus Therapeutics and serves on the Fabry Outcome Survey (FOS) International Advisory Board. Dr. Strotmann has received research support and speaking fees from Genzyme. Dr. West has received speaking fees, research funding, and/or consultant fees from Genzyme, Shire HGT, Amicus Therapeutics, and Sumitomo Pharma. All other authors have reported that they have no relationships to disclose.